Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group.
Neuberger JM, Bechstein WO, Kuypers DR, Burra P, Citterio F, De Geest S, Duvoux C, Jardine AG, Kamar N, Krämer BK, Metselaar HJ, Nevens F, Pirenne J, Rodríguez-Perálvarez ML, Samuel D, Schneeberger S, Serón D, Trunečka P, Tisone G, van Gelder T. Neuberger JM, et al. Among authors: duvoux c. Transplantation. 2017 Apr;101(4S Suppl 2):S1-S56. doi: 10.1097/TP.0000000000001651. Transplantation. 2017. PMID: 28328734 Free article.
Tacrolimus (FK506)-based dual versus triple therapy following liver transplantation.
Samuel D, Bismuth H, Boillot O, Ducerf C, Baulieux J, Gugenheim J, Baldini E, Launois B, Messner M, Wolf P, Ellero E, Domergue J, Pageaux J, Cherqui D, Duvoux C, Durand F, Belghiti J, Calmus Y, Massault PP, Neau-Cransac M, Saric J, LeTreut Y, Campan P. Samuel D, et al. Among authors: duvoux c. Transplant Proc. 1998 Jun;30(4):1394-6. doi: 10.1016/s0041-1345(98)00286-3. Transplant Proc. 1998. PMID: 9636563 Clinical Trial. No abstract available.
Inhibitor against coagulation factor V after liver transplantation.
Leroy-Matheron C, Mallat A, Duvoux C, Métreau JM, Cherqui D, Dhumeaux D, Gouault-Heilmann M. Leroy-Matheron C, et al. Among authors: duvoux c. Transplantation. 1999 Oct 15;68(7):1054-6. doi: 10.1097/00007890-199910150-00026. Transplantation. 1999. PMID: 10532550
Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients.
Nevens F, Zuckerman JN, Burroughs AK, Jung MC, Bayas JM, Kallinowski B, Rivas EF, Duvoux C, Neuhaus P, Saliba F, Buti M, Zarski JP, Pons F, Vanlemmens C, Hamtiaux V, Stoffel M. Nevens F, et al. Among authors: duvoux c. Liver Transpl. 2006 Oct;12(10):1489-95. doi: 10.1002/lt.20836. Liver Transpl. 2006. PMID: 16964595 Free article. Clinical Trial.
[Hepatic transplantation].
Duvoux C, Samuel D. Duvoux C, et al. Gastroenterol Clin Biol. 2009 Aug-Sep;33(8-9):868-81. doi: 10.1016/j.gcb.2009.05.003. Epub 2009 Jun 24. Gastroenterol Clin Biol. 2009. PMID: 19556084 Free article. Review. French.
236 results